id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0012-0001,FDA,FDA-1975-N-0012,Draft FRN - Topical Antimicrobial Drug Products for Over-the Counter Human Use; Tentative Final Monograph for Health-Care Antiseptic Drug Products; Extension of Comment and New Data Periods,Proposed Rule,Notice of Extension,1994-11-28T05:00:00Z,1994,11,1994-11-28T05:00:00Z,2019-04-04T03:59:59Z,2019-04-03T01:03:54Z,FR Doc. 94- 28063,0,0,09000064805c1908
FDA-1975-N-0012-0049,FDA,FDA-1975-N-0012,Request for Extension from Amway Corporation,Other,Request for Extension,1994-10-13T04:00:00Z,1994,10,,,2017-11-20T17:41:08Z,,0,0,09000064805c1947
FDA-1975-N-0012-0044,FDA,FDA-1975-N-0012,Topical Antimicrobial Drug Products for Over-the Counter Human Use; Tentative Final Monograph for Health-Care Antiseptic Drug Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1994-06-16T04:00:00Z,1994,6,1994-06-16T04:00:00Z,1994-12-15T04:59:59Z,2017-10-16T12:01:00Z,94-14503,0,0,09000064805c190b